SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
23.41
-1.98 (-7.80%)
At close: May 8, 2026, 4:00 PM EDT
23.40
-0.01 (-0.04%)
After-hours: May 8, 2026, 4:04 PM EDT
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $782.52 million as of May 8, 2026.
Market Cap
782.52M
Enterprise Value
676.66M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.41
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $782.52M, an increase of 53.26%. That is a compound annual growth rate of 454.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 782.52M | -7.80% |
| May 7, 2026 | 848.70M | 1.34% |
| May 6, 2026 | 837.50M | 2.64% |
| May 5, 2026 | 815.94M | - |
| May 4, 2026 | 815.94M | 1.79% |
| May 1, 2026 | 801.57M | 4.53% |
| Apr 30, 2026 | 766.81M | 3.66% |
| Apr 29, 2026 | 739.73M | -3.78% |
| Apr 28, 2026 | 768.81M | -2.75% |
| Apr 27, 2026 | 790.54M | 0.55% |
| Apr 24, 2026 | 786.19M | -0.47% |
| Apr 23, 2026 | 789.87M | -3.51% |
| Apr 22, 2026 | 818.62M | 0.16% |
| Apr 21, 2026 | 817.28M | -0.29% |
| Apr 20, 2026 | 819.62M | -1.68% |
| Apr 17, 2026 | 833.66M | -0.36% |
| Apr 16, 2026 | 836.67M | 1.21% |
| Apr 15, 2026 | 826.64M | 0.86% |
| Apr 14, 2026 | 819.62M | 2.72% |
| Apr 13, 2026 | 797.89M | 15.04% |
| Apr 10, 2026 | 693.60M | -2.21% |
| Apr 9, 2026 | 709.31M | -4.50% |
| Apr 8, 2026 | 742.74M | 5.46% |
| Apr 7, 2026 | 704.30M | -6.98% |
| Apr 6, 2026 | 757.11M | 0.85% |
| Apr 2, 2026 | 750.76M | -8.10% |
| Apr 1, 2026 | 816.95M | -5.67% |
| Mar 31, 2026 | 866.08M | 10.87% |
| Mar 30, 2026 | 781.18M | 3.36% |
| Mar 27, 2026 | 755.77M | -10.28% |
| Mar 26, 2026 | 842.35M | 0.25% |
| Mar 25, 2026 | 840.27M | 6.23% |
| Mar 24, 2026 | 790.96M | -9.91% |
| Mar 23, 2026 | 877.91M | 1.35% |
| Mar 20, 2026 | 866.25M | 1.13% |
| Mar 19, 2026 | 856.59M | -4.07% |
| Mar 18, 2026 | 892.91M | -1.47% |
| Mar 17, 2026 | 906.23M | 0.37% |
| Mar 16, 2026 | 902.90M | 2.07% |
| Mar 13, 2026 | 884.58M | 0.49% |
| Mar 12, 2026 | 880.25M | -2.51% |
| Mar 11, 2026 | 902.90M | 1.04% |
| Mar 10, 2026 | 893.57M | -1.11% |
| Mar 9, 2026 | 903.57M | 1.65% |
| Mar 6, 2026 | 888.91M | 0.98% |
| Mar 5, 2026 | 880.25M | -0.97% |
| Mar 4, 2026 | 888.91M | -0.26% |
| Mar 3, 2026 | 891.24M | 0.07% |
| Mar 2, 2026 | 890.57M | -4.54% |
| Feb 27, 2026 | 932.89M | -1.23% |
| Feb 26, 2026 | 944.55M | -2.68% |
| Feb 25, 2026 | 970.54M | -0.55% |
| Feb 24, 2026 | 975.87M | -0.20% |
| Feb 23, 2026 | 977.87M | 0.10% |
| Feb 20, 2026 | 976.87M | -1.21% |
| Feb 19, 2026 | 988.86M | 4.14% |
| Feb 18, 2026 | 949.55M | 2.93% |
| Feb 17, 2026 | 922.56M | -1.88% |
| Feb 13, 2026 | 940.22M | 2.62% |
| Feb 12, 2026 | 916.23M | -0.18% |
| Feb 11, 2026 | 917.89M | -1.01% |
| Feb 10, 2026 | 927.22M | 6.30% |
| Feb 9, 2026 | 872.25M | 70.84% |
| Feb 6, 2026 | 510.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 865.65M |
| Alto Neuroscience | 861.25M |
| Pharming Group | 860.79M |
| Arbutus Biopharma | 857.67M |
| CytomX Therapeutics | 850.09M |
| Evommune | 835.99M |
| Kura Oncology | 829.93M |
| Seaport Therapeutics | 826.83M |